COVID Town Hall - Part 1 Save
Part I Panel Questions
0:00 Introduction
1:22 How has the COVID-19 pandemic affected you?
4:09 What’s the most common question you’re getting and what is your response?
8:06 What adjustments have you made in your practice or how has your practice changed?
13:13 Things we are not doing anymore…
13:40 Questions amongst panelists
13:33 A Kavanaugh (to K Winthrop) What’s the evidence favoring the evidence hydroxychloroquine (French Study)
16:40 J Cush (to C Calabrese) Is azithromycin an effective COVID therapy?
17:45 C Calabrese (to K Winthrop) What about “Universal Masking”?
20:24 A Matsumoto (to ID docs CC, KW) When can patients (or healthcare workers) resume infliximab infusions after being symptomatic?
24:23 A Wells (to AK) what to do with trainees during this “shutdown”?
25:55 A Wells (to CC) What about the new 15 min test vs the ‘real time' (PCR) test?
26:22 J Cush on the Global Rheumatology Alliance - rheum-covid.org
27:25 Are Rheumatic patients “at-risk” for COVID-19 infection or worse outcomes?
Transcription
Hello everybody watching, the COVID town hall here on RoomNow. I'm Jack Cush, theroomnow.com. I'm joined by five of my friends, expert panelists who I've asked to, join us because of their each, different but unique perspectives on practice rheumatology and dealing with this particular pandemic and how it affects us in rheumatology.



If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.